Dr. P K Das

Dr. P K Das is a senior medical oncologist with over 21 years of experience, currently serving as Senior Consultant and Haemato‑Oncologist at Apollo Cancer Institute, New Delhi.
He is known for his comprehensive cancer care and patient‑centric approach — offering personalised treatment plans tailored to each patient’s condition and needs.
Dr. Das manages a wide spectrum of cancers — both solid tumors and hematologic malignancies — ensuring accurate diagnosis, advanced therapy, and ongoing support for patients throughout their treatment journey.

• Apollo Hospital, Delhi

• MBBS
• MD (General Medicine)
• DM (Medical Oncology) – from All India Institute of Medical Sciences (AIIMS), New Delhi

• Senior Consultant Medical Oncologist & Haemato‑Oncologist, Apollo Cancer Institute, New Delhi
• Academic Coordinator — Department of Medical Oncology, Apollo Hospital, Delhi
• In‑charge of Medical Oncology Unit I at Apollo Hospital, overseeing diagnosis, therapy planning, and follow-up treatment for cancer patients
• More than 21 years of experience in oncology, blood disorders, and comprehensive cancer care

• Diagnosis and treatment of solid tumors (breast, lung, colon, prostate, liver, pancreas, kidney, and more)
• Hematologic malignancies — leukemia, lymphoma, multiple myeloma, and other blood disorders
• Chemotherapy, targeted therapy, and immunotherapy tailored to patient’s cancer type and stage
• Supportive care, palliative care, and long‑term follow-up plans to ensure holistic treatment and improved quality of life

• Oncology

• Over 50 peer‑reviewed publications and significant research contributions in oncology and hematology.
• Presented internationally awarded research — e.g., research on circulating micromegakaryocytes in CML won first prize at the 11th International Congress on Anti-Cancer Treatment in Paris.
• Authored important case reports including rare malignancies, contributing to medical literature and knowledge.
• Active member of national and international oncology organizations — including Indian Society of Medical & Paediatric Oncology (ISMPO), European Society for Medical Oncology (ESMO), and American Society of Clinical Oncology (ASCO).
• Served on expert committees for drug regulation and advisory panels under the government for oncology care and policy.